Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk

Endocrine Reviews

Volumn 31, Issue 6, 2010, Pages 817-844

  Manco, Melania ^a   Putignani, Lorenza ^a   Bottazzo, Gian Franco ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4;

ADIPOSE TISSUE; ATHEROSCLEROTIC PLAQUE; BACTEROIDES; CARDIOVASCULAR RISK; ENDOTOXEMIA; FATTY LIVER; FIRMICUTES; GENE EXPRESSION; GLUCOSE METABOLISM; GRAM NEGATIVE SEPSIS; HUMAN; INFLAMMATION; INNATE IMMUNITY; INSULIN METABOLISM; INSULIN RESISTANCE; INTESTINE FLORA; LIPID STORAGE; LIVER; MUSCLE TISSUE; OBESITY; PRIORITY JOURNAL; REVIEW; WEIGHT GAIN;

CARDIOVASCULAR DISEASES; GASTROINTESTINAL TRACT; HUMANS; IMMUNITY, INNATE; LIPOPOLYSACCHARIDES; OBESITY;

EID: 78650465542     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.2009-0030     Document Type: Review

References (249)

1. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA 2005 Diversity of thehumanintestinal microbial flora. Science 308:1635-1638
2. Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI 2005 Host-bacterial mutualism in the human intestine. Science 307:1915-1920
3. Barrett KE 2009 The world within - impact of the intestinal microbiota on whole body physiology and pathophysiology. J Physiol 587:4151
4. Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI 2004 The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 101:15718-15723 (Pubitemid 39473554)
5. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmée E, Cousin B, Sulpice T, Chamontin B, Ferrières J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R 2007 Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56:1761-1772
6. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R 2008 Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57:1470-1481
7. Creely SJ, McTernan PG, Kusminski CM, Fisher M, Da Silva NF, Khanolkar M, Evans M, Harte AL, Kumar S 2007 Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 292:E740-E747 (Pubitemid 46411051)
8. Chung S, Lapoint K, Martinez K, Kennedy A, Boysen Sandberg M, McIntosh MK 2006 Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes. Endocrinology 147:5340-5351 (Pubitemid 44790589)
9. Miller MA, Cappuccio FP 2009 Endotoxin and metabolic syndrome. Atherosclerosis 206:37
10. Manco M 2009 Endotoxin as a missed link among all the metabolic abnormalities in the metabolic syndrome. Atherosclerosis 206:36
11. Stoll LL, Denning GM, Weintraub NL 2004 Potential role of endotoxin as a proinflammatory mediator of atherosclerosis. Arterioscler Thromb Vasc Biol 24:2227-2236 (Pubitemid 39658022)
12. Beutler B, Hoebe K, Du X, Ulevitch RJ 2003 How we detect microbes and respond to them: the Toll-like receptors and their transducers. J Leukoc Biol 74:479-485 (Pubitemid 38040374)
13. Bettelheim KA, Breadon A, Faiers MC, O'Farrell SM, Shooter RA 1974 The origin of Oserotypes of Escherichia coli in babies after normal delivery. J Hyg (Lond) 72:67-70
14. Bezirtzoglou E 1997 The intestinal microflora during the first weeks of life. Anaerobe 3:173-177 (Pubitemid 27423147)
15. Adlerberth I, Wold AE 2009 Establishment of the gut microbiota in Western infants. Acta Paediatr 98:229-238
16. Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, van den Brandt PA, Stobberingh EE 2006 Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118:511-521 (Pubitemid 46085405)
17. Grönlund MM, Lehtonen OP, Eerola E, Kero P 1999 Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. J Pediatr Gastroenterol Nutr 28:19-25 (Pubitemid 29292870)
18. Bennet R, Nord CE 1987 Development of the faecal anaerobic microflora after caesarean section and treatment with antibiotics in newborn infants. Infection 15:332-336 (Pubitemid 17156104)
19. Heavey PM, Savage SA, Parrett A, Cecchini C, Edwards CA, Rowland IR 2003 Protein-degradation products and bacterial enzyme activities in faeces of breast-fed and formula-fed infants. Br J Nutr 89:509-515 (Pubitemid 36582121)
20. Coppa GV, Bruni S, Morelli L, Soldi S, Gabrielli O 2004 The first prebiotics in humans: human milk oligosaccharides. J Clin Gastroenterol 38:S80-S83
21. Ley RE, Turnbaugh PJ, Klein S, Gordon JI 2006 Microbial ecology: human gut microbes associated with obesity. Nature 444:1022-1023 (Pubitemid 46018512)
22. Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R 2009 Bacterial community variation in human body habitats across space and time. Science 326:1694-1697
23. Zoetendal EG, Vaughan EE, de Vos WM 2006 A microbial world within us. Mol Microbiol 59:1639-1650
24. Hooper LV, Gordon JI 2001 Commensal host-bacterial relationships in the gut. Science 292:1115-1118
25. Guarner F, Malagelada JR 2003 Gut flora in health and disease. Lancet 361:512-519
26. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO 2007 Development of the human infant intestinal microbiota. PLoS Biol 5:e177
27. Whitman WB, Coleman DC, Wiebe WJ 1998 Prokaryotes: the unseen majority. Proc Natl Acad Sci USA 95:6578-6583
28. Hugenholtz P, Goebel BM, Pace NR 1998 Impact of culture-independent studies on the emerging phylogenetic view of bacterial diversity. J Bacteriol 180:4765-4774
29. Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, Gordon JI, Relman DA, Fraser-Liggett CM, Nelson KE 2006 Metagenomic analysis of thehumandistal gut microbiome. Science 312:1355-1359 (Pubitemid 43839542)
30. Bergman EN 1990 Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiol Rev 70:567-590
31. Macdonald TT, Monteleone G 2005 Immunity, inflammation, and allergy in the gut. Science 307:1920-1925
32. Macpherson AJ, Geuking MB, McCoy KD 2005 Immune responses that adapt the intestinal mucosa to commensal intestinal bacteria. Immunology 115:153-162
33. Philpott DJ, Girardin SE 2004 The role of Toll-like receptors and Nod proteins in bacterial infection. Mol Immunol 41:1099-1108 (Pubitemid 39345391)
34. Gewirtz AT, Navas TA, Lyons S, Godowski PJ, Madara JL 2001 Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol 167:1882-1885 (Pubitemid 32747491)
35. Hornef MW, Normark BH, Vandewalle A, Normark S 2003 Intracellular recognition of lipopolysaccharide by toll-like receptor 4 in intestinal epithelial cells. J Exp Med 198:1225-1235 (Pubitemid 37323387)
36. Kelly D, Conway S 2005 Bacterial modulation of mucosal innate immunity. Mol Immunol 42:895-901 (Pubitemid 40489013)
37. Kelly D, Campbell JI, King TP, Grant G, Jansson EA, Coutts AG, Pettersson S, Conway S 2004 Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-γ and RelA. Nat Immunol 5:104-112 (Pubitemid 38081475)
38. Wald D, Qin J, Zhao Z, Qian Y, Naramura M, Tian L, Towne J, Sims JE, Stark GR, Li X 2003 SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat Immunol 4:920-927 (Pubitemid 37098664)
39. Zhang G, Ghosh S 2002 Negative regulation of toll-like receptor-mediated signaling by Tollip. J Biol Chem 277: 7059-7065 (Pubitemid 34953094)
40. Brint EK, Xu D, Liu H, Dunne A, McKenzie AN, O'Neill LA, Liew FY 2004 ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat Immunol 5:373-379 (Pubitemid 38500085)
41. Chamaillard M, Girardin SE, Viala J, Philpott DJ 2003 Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation. Cell Microbiol 5:581-592
42. Otte JM, Cario E, Podolsky DK 2004 Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 126:1054-1070 (Pubitemid 38451177)
43. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP, Egholm M, Henrissat B, Heath AC, Knight R, Gordon JI 2009 A core gut microbiome in obese and lean twins. Nature 457:480-484
44. Turnbaugh PJ, Gordon JI 2009 The core gut microbiome, energy balance and obesity. J Physiol 587:4153-4158
45. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI 2006 An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:1027-1031 (Pubitemid 46018515)
46. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI 2005 Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 102:11070-11075 (Pubitemid 41105994)
47. Bäckhed F, Manchester JK, Semenkovich CF, Gordon JI 2007 Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 104:979-984 (Pubitemid 46154722)
48. Towle HC 2001 Glucose and cAMP: adversaries in the regulation of hepatic gene expression. Proc Natl Acad Sci USA 98:13476-13478 (Pubitemid 33115920)
49. Dentin R, Pégorier JP, Benhamed F, Foufelle F, Ferré P, Fauveau V, Magnuson MA, Girard J, Postic C 2004 Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression. J Biol Chem 279:20314-20326 (Pubitemid 38623477)
50. Yoshida K, Shimizugawa T, Ono M, Furukawa H 2002 Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase. J Lipid Res 43:1770-1772 (Pubitemid 35315796)
51. Xue B, Kahn BB 2006 AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues. J Physiol 574:73-83 (Pubitemid 43905798)
52. Kahn BB, Alquier T, Carling D, Hardie DG 2005 AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1:15-25 (Pubitemid 43960587)
53. Ruderman NB, Saha AK 2006 Metabolic syndrome: adenosine monophoshate-activated protein kinase and malonyl coenzyme A. Obesity 14:25S-33S
54. Raetz CR 1990 Biochemistry of endotoxins. Annu Rev Biochem 59:129-170
55. Munford RS, Hall CL 1986 Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme. Science 234:203-205
56. Kitchens RL, Ulevitch RJ, Munford RS 1992 Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway. J Exp Med 176:485-494
57. Erridge C, Attina T, Spickett CM, Webb DJ 2007 A highfat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 86:1286-1292 (Pubitemid 350126229)
58. Ghoshal S, Witta J, Zhong J, de Villiers W, Eckhardt E 2009 Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res 50:90-97
59. Brun P, Castagliuolo I, Di Leo V, Buda A, Pinzani M, Palù G, Martines D 2007 Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 292:G518-G525
60. Velasquez OR, Henninger K, Fowler M, Tso P, Crissinger KD 1993 Oleic acid-induced mucosal injury in developing piglet intestine. Am J Physiol 264:G576-G582
61. Levels JH, Abraham PR, van den Ende A, van Deventer SJ 2001 Distribution and kinetics of lipoprotein-bound endotoxin. Infect Immun 69:2821-2828
62. Hathaway LJ, Kraehenbuhl JP 2000 The role of M cells in mucosal immunity. Cell Mol Life Sci 57:323-332
63. Neal MD, Leaphart C, Levy R, Prince J, Billiar TR, Watkins S, Li J, Cetin S, Ford H, Schreiber A, Hackam DJ 2006 Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. J Immunol 176:3070-3079
64. Lotz M, Gütle D, Walther S, Ménard S, Bogdan C, Hornef MW 2006 Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. J Exp Med 203:973-984
65. Abreu MT, Arnold ET, Thomas LS, Gonsky R, Zhou Y, Hu B, Arditi M 2002 TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. J Biol Chem 277:20431-20437 (Pubitemid 34967339)
66. Hornef MW, Frisan T, Vandewalle A, Normark S, Richter-Dahlfors A 2002 Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J Exp Med 195:559-570 (Pubitemid 34461501)
67. Munford RS, Andersen JM, Dietschy JM 1981 Sites of tissue binding and uptake in vivo of bacterial lipopolysaccharide-high density lipoprotein complexes: studies in the rat and squirrel monkey. J Clin Invest 68:1503-1513
68. Read TE, Harris HW, Grunfeld C, Feingold KR, Calhoun MC, Kane JP, Rapp JH 1993 Chylomicrons enhance endotoxin excretion in bile. Infect Immun 61:3496-3502 (Pubitemid 23223444)
69. Parker TS, Levine DM, Chang JC, Laxer J, Coffin CC, Rubin AL 1995 Reconstituted high-density lipoprotein neutralizes Gram-negative bacterial lipopolysaccharides in human whole blood. Infect Immun 63:253-258
70. Wurfel MM, Wright SD 1997 Lipopolysaccharide-binding protein and soluble CD14 transfer lipopolysaccharide to phospholipid bilayers: preferential interaction with particular classes of lipid. J Immunol 158:3925-3934
71. Levine DM, Parker TS, Donnelly TM, Walsh A, Rubin AL 1993 In vivo protection against endotoxin by plasma high density lipoprotein. Proc Natl Acad Sci USA 90:12040-12044
72. Goldfarb RD, Parker TS, Levine DM, Glock D, Akhter I, Alkhudari A, McCarthy RJ, David EM, Gordon BR, Saal SD, Rubin AL, Trenholme GM, Parrillo JE 2003 Protein-free phospholipid emulsion treatment improved cardiopulmonary function and survival in porcine sepsis. Am J Physiol Regul Integr Comp Physiol 284:R550-R557
73. Vesy CJ, Kitchens RL, Wolfbauer G, Albers JJ, Munford RS 2000 Lipopolysaccharide-binding protein and phospholipid transfer protein release lipopolysaccharides from Gram-negative bacterial membranes. Infect Immun 68:2410-2417 (Pubitemid 30253806)
74. Schwartz YSh, Dushkin MI 2002 Endotoxin-lipoprotein complex formation as a factor in atherogenesis: associations with hyperlipidemia and with lecithin:cholesterol acyltransferase activity. Biochemistry Mosc 67:747-752
75. Levels JH, Marquart JA, Abraham PR, van den Ende AE, Molhuizen HO, van Deventer SJ, Meijers JC 2005 Lipopolysaccharide is transferred from high-density to lowdensity lipoproteins by lipopolysaccharide-binding protein and phospholipid transfer protein. Infect Immun 73:2321-2326
76. Kitchens RL, Thompson PA, Munford RS, O'Keefe GE 2003 Acute inflammation and infection maintain circulating phospholipid levels and enhance lipopolysaccharide binding to plasma lipoproteins. J Lipid Res 44:2339-2348
77. Cavaillon JM, Fitting C, Haeffner-Cavaillon N, Kirsch SJ, Warren HS 1990 Cytokine response by monocytes and macrophages to free and lipoprotein-bound lipopolysaccharide. Infect Immun 58:2375-2382 (Pubitemid 20212321)
78. Harris HW, Grunfeld C, Feingold KR, Read TE, Kane JP, Jones AL, Eichbaum EB, Bland GF, Rapp JH 1993 Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J Clin Invest 91:1028-1034 (Pubitemid 23095278)
79. Kitchens RL, Wolfbauer G, Albers JJ, Munford RS 1999 Plasma lipoproteins promote the release of bacterial lipopolysaccharide from the monocyte cell surface. J Biol Chem 274:34116-34122 (Pubitemid 129511747)
80. Kitchens RL, Thompson PA, Viriyakosol S, O'Keefe GE, Munford RS 2001 Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins. J Clin Invest 108:485-493 (Pubitemid 32730795)
81. Wang Z, Xiao G, Yao Y, Guo S, Lu K, Sheng Z 2006 The role of Bifidobacteria in gut barrier function after thermal injury in rats. J Trauma 61:650-657 (Pubitemid 44400949)
82. Caplan MS, Miller-Catchpole R, Kaup S, Russell T, Lickerman M, Amer M, Xiao Y, Thomson Jr R 1999 Bifidobacterial supplementation reduces the incidence of necrotizing enterocolitis in a neonatal rat model. Gastroenterology 117:577-583 (Pubitemid 29409243)
83. Lee JY, Zhao L, Hwang DH 2010 Modulation of pattern recognition receptor-mediated inflammation and risk of chronic diseases by dietary fatty acids. Nutr Rev 68:38-61
84. McGarry JD 1992 What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258:766-770
85. Virtue S, Vidal-Puig A 2008 It's not how fat you are, it's what you do with it that counts. PLoS Biol 6:e237
86. Mitaka C 2005 Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome. Clin Chim Acta 351:17-29 (Pubitemid 39567312)
87. Langhans W 2000 Anorexia of infection: current prospects. Nutrition 16:996-1005
88. Saltiel AR, Pessin JE 2002 Insulin signaling pathways in time and space. Trends Cell Biol 12:65-71
89. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM 1996 IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance. Science 271:665-668 (Pubitemid 26052915)
90. Shoelson SE, Lee J, Yuan M 2003 Inflammation and the IKK β/IκB/NF-κB axis in obesity - and diet-induced insulin resistance. Int J Obes Relat Metab Disord 27(Suppl 3):S49-S52
91. Schenk S, Saberi M, Olefsky JM 2008 Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest 118:2992-3002
92. Nakatani Y, Kaneto H, Kawamori D, Hatazaki M, Miyatsuka T, Matsuoka TA, Kajimoto Y, Matsuhisa M, Yamasaki Y, Hori M 2004 Modulation of the JNK pathway in liver affects insulin resistance status. J Biol Chem 279:45803-45809 (Pubitemid 39491572)
93. Gao Z, Hwang D, Bataille F, Lefevre M, York D, Quon MJ, Ye J 2002 Serine phosphorylation of insulin receptor substrate 1 by inhibitor κB kinase complex. J Biol Chem 277:48115-48121 (Pubitemid 35470759)
94. Cornell RP 1980 Mechanisms of acute hyperinsulinemia after Kupffer cell phagocytosis. Am J Physiol 238:E276-E283
95. Rui L, Yuan M, Frantz D, Shoelson S, White MF 2002 SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem 277:42394-42398 (Pubitemid 35257562)
96. Mooney RA, Senn J, Cameron S, Inamdar N, Boivin LM, Shang Y, Furlanetto RW 2001 Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance. J Biol Chem 276:25889-25893
97. Perreault M, Marette A 2001 Targeted disruption of inducible nitric oxide synthase protects against obesitylinked insulin resistance in muscle. Nat Med 7:1138-1143 (Pubitemid 33010023)
98. Song MJ, Kim KH, Yoon JM, Kim JB 2006 Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem Biophys Res Commun 346:739-745
99. Samokhvalov V, Bilan PJ, Schertzer JD, Antonescu CN, Klip A 2009 Palmitate- and lipopolysaccharide-activated macrophages evoke contrasting insulin responses in muscle cells. Am J Physiol Endocrinol Metab 296:E37-E46
100. van der Crabben SN, Blümer RM, Stegenga ME, Ackermans MT, Endert E, Tanck MW, Serlie MJ, van der Poll T, Sauerwein HP 2009 Early endotoxemia increases peripheral and hepatic insulin sensitivity in healthy humans. J Clin Endocrinol Metab 94:463-468
101. Anderson PD, Mehta NN, Wolfe ML, Hinkle CC, Pruscino L, Comiskey LL, Tabita-Martinez J, Sellers KF, Rickels MR, Ahima RS, Reilly MP 2007 Innate immunity modulates adipokines in humans. J Clin Endocrinol Metab 92:2272-2279 (Pubitemid 46997133)
102. Kapur S, Picard F, Perreault M, Deshaies Y, Marette A 2000 Nitric oxide: a new player in the modulation of energy metabolism. Int J Obes Relat Metab Disord 24(Suppl 4):S36-S40
103. Bédard S, Marcotte B, Marette A 1997 Cytokines modulate glucose transport in skeletal muscle by inducing the expression of inducible nitric oxide synthase. Biochem J 325:487-493 (Pubitemid 27338732)
104. Kapur S, Bédard S, Marcotte B, Côté CH, Marette A 1997 Expression of nitric oxide synthase in skeletal muscle: a novel role for nitric oxide as a modulator of insulin action. Diabetes 46:1691-1700 (Pubitemid 27456399)
105. Agwunobi AO, Reid C, Maycock P, Little RA, Carlson GL 2000 Insulin resistance and substrate utilization in human endotoxemia. J Clin Endocrinol Metab 85:3770-3778
106. Raetzsch CF, Brooks NL, Alderman JM, Moore KS, Hosick PA, Klebanov S, Akira S, Bear JE, Baldwin AS, Mackman N, Combs TP 2009 Lipopolysaccharide inhibition of glucose production through the Toll-like receptor-4, myeloid differentiation factor 88, and nuclear factor κB pathway. Hepatology 50:592-600
107. Titheradge MA, Knowles RG, Smith FS, Horton RA, Ceppi ED 1995 Mechanism of inhibition of hepatic gluconeogenesis by bacterial endotoxin: a role for nitric oxide? Biochem Soc Trans 23:1002-1008
108. Maitra SR, Gestring ML, El-Maghrabi MR, Lang CH, Henry MC 1999 Endotoxin-induced alterations in hepatic glucose-6-phosphatase activity and gene expression. Mol Cell Biochem 196:79-83
109. Spitzer JJ, Bagby GJ, Mészáros K, Lang CH 1988 Alterations in lipid and carbohydrate metabolism in sepsis. JPEN J Parenter Enteral Nutr 12:53S-58S
110. Walrand S, Guillet C, Boirie Y, Vasson MP 2004 In vivo evidences that insulin regulates human polymorphonuclear neutrophil functions. J Leukoc Biol 76:1104-1110
111. Muzio M, Polentarutti N, Bosisio D, Manoj Kumar PP, Mantovani A 2000 Toll-like receptor family and signalling pathway. Biochem Soc Trans 28:563-566
112. Hasday JD, Bascom R, Costa JJ, Fitzgerald T, Dubin W 1999 Bacterial endotoxin is an active component of cigarette smoke. Chest 115:829-835 (Pubitemid 29129968)
113. Byrne MM, Pluntke K, Wank U, Schirra J, Arnold R, Göke B, Katschinski M 1998 Inhibitory effects of hyperglycaemia on fed jejunal motility: potential role of hyperinsulinaemia. Eur J Clin Invest 28:72-78 (Pubitemid 28062482)
114. Cuoco L, Montalto M, Jorizzo RA, Santarelli L, Arancio F, Cammarota G, Gasbarrini G 2002 Eradication of small intestinal bacterial overgrowth and oro-cecal transit in diabetics. Hepatogastroenterology 49:1582-1586 (Pubitemid 35277332)
115. Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM 1997 Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci USA 94:2557-2562 (Pubitemid 27136914)
116. Chinetti G, Fruchart JC, Staels B 2000 Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res 49:497-505
117. Chiquette E, Ramirez G, Defronzo R 2004 A meta-analysis comparing the effect of thiazolidinediones on cardiovascular risk factors. Arch Intern Med 164:2097-2104 (Pubitemid 39419498)
118. Festa A, D'Agostino Jr R, Tracy RP, Haffner SM, Insulin Resistance Atherosclerosis Study 2002 Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 51:1131-1137 (Pubitemid 34438360)
119. Manco M, Bottazzo G, DeVito R, Marcellini M, Mingrone G, Nobili V 2008 Nonalcoholic fatty liver disease in children. J Am Coll Nutr 27:667-676
120. Day CP, James OF 1998 Steatohepatitis: a tale of two "hits?" Gastroenterology 114:842-845
121. Malhi H, Bronk SF, Werneburg NW, Gores GJ 2006 Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. J Biol Chem 281:12093-12101 (Pubitemid 43855473)
122. Joshi-Barve S, Barve SS, Amancherla K, Gobejishvili L, Hill D, Cave M, Hote P, McClain CJ 2007 Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes. Hepatology 46:823-830 (Pubitemid 47436129)
123. Wang D, Wei Y, Pagliassotti MJ 2006 Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. Endocrinology 147:943-951 (Pubitemid 43113013)
124. Ueki K, Kondo T, Tseng YH, Kahn CR 2004 Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. Proc Natl Acad Sci USA 101:10422-10427 (Pubitemid 38924941)
125. Hirosumi J, Tuncman G, Chang L, Görgün CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS 2002 A central role for JNK in obesity and insulin resistance. Nature 420:333-336 (Pubitemid 35398190)
126. Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poli G, Olefsky J, Karin M 2005 IKK-β links inflammation to obesity-induced insulin resistance. Nat Med 11:191-198 (Pubitemid 40321355)
127. Schattenberg JM, Singh R, Wang Y, Lefkowitch JH, Rigoli RM, Scherer PE, Czaja MJ 2006 JNK1 but not JNK2 promotes the development of steatohepatitis in mice. Hepatology 43:163-172 (Pubitemid 43733603)
128. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE 2005 Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB. Nat Med 11:183-190 (Pubitemid 40321354)
129. Pagliassotti MJ, Wei Y, Wang D 2007 Insulin protects liver cells from saturated fatty acid-induced apoptosis via inhibition of c-Jun NH2 terminal kinase activity. Endocrinology 148:3338-3345 (Pubitemid 46996986)
130. Ribeiro PS, Cortez-Pinto H, Solá S, Castro RE, Ramalho RM, Baptista A, Moura MC, Camilo ME, Rodrigues CM 2004 Hepatocyte apoptosis, expression of death receptors, and activation of NF-κB in the liver of nonalcoholic and alcoholic steatohepatitis patients. Am J Gastroenterol 99:1708-1717 (Pubitemid 39237497)
131. Zou C, Ma J, Wang X, Guo L, Zhu Z, Stoops J, Eaker AE, Johnson CJ, Strom S, Michalopoulos GK, DeFrances MC, Zarnegar R 2007 Lack of Fas antagonism by Met inhuman fatty liver disease. Nat Med 13:1078-1085 (Pubitemid 47517506)
132. Feldstein AE, Canbay A, Guicciardi ME, Higuchi H, Bronk SF, Gores GJ 2003 Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice. J Hepatol 39:978-983 (Pubitemid 37523769)
133. Maher JJ, Leon P, Ryan JC 2008 Beyond insulin resistance: innate immunity in nonalcoholic steatohepatitis. Hepatology 48:670-678
134. Mencin A, Kluwe J, Schwabe RF 2009 Toll-like receptors as targets in chronic liver diseases. Gut 58:704-720
135. Mathurin P, Deng QG, Keshavarzian A, Choudhary S, Holmes EW, Tsukamoto H 2000 Exacerbation of alcoholic liver injury by enteral endotoxin in rats. Hepatology 32:1008-1017
136. Parlesak A, Schäfer C, Schütz T, Bode JC, Bode C 2000 Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J Hepatol 32:742-747 (Pubitemid 30262733)
137. Adachi Y, Moore LE, Bradford BU, Gao W, Thurman RG 1995 Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 108:218-224
138. Rao R 2009 Endotoxemia and gut barrier dysfunction in alcoholic liver disease. Hepatology 50:638-644
139. Purohit V, Bode JC, Bode C, Brenner DA, Choudhry MA, Hamilton F, Kang YJ, Keshavarzian A, Rao R, Sartor RB, Swanson C, Turner JR 2008 Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium. Alcohol 42:349-361
140. Järveläinen HA, Fang C, Ingelman-Sundberg M, Lindros KO 1999 Effect of chronic coadministration of endotoxin and ethanol on rat liver pathology and proinflammatory and anti-inflammatory cytokines. Hepatology 29:1503-1510
141. Fukui H, Kitano H, Okamoto Y, Kikuchi E, Matsumoto M, Kikukawa M, Morimura M, Tsujita S, Nagamoto I, Nakatani T 1995 Interaction of Kupffer cells to splenic macrophages and hepatocytes in endotoxin clearance: effect of alcohol. J Gastroenterol Hepatol 10(Suppl 1):S31-S34
142. Hritz I, Mandrekar P, Velayudham A, Catalano D, Dolganiuc A, Kodys K, Kurt-Jones E, Szabo G 2008 The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88. Hepatology 48:1224-1231
143. Yin M, Wheeler MD, Kono H, Bradford BU, Gallucci RM, Luster MI, Thurman RG 1999 Essential role of tumor necrosis factor α in alcohol-induced liver injury in mice. Gastroenterology 117:942-952 (Pubitemid 29468238)
144. Crespo J, Cayón A, Fernández-Gil P, Hernández-Guerra M, Mayorga M, Domínguez-Díez A, Fernández-Escalante JC, Pons-Romero F 2001 Gene expression of tumor necrosis factor α and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology 34:1158-1163 (Pubitemid 33096588)
145. Wheeler MD 2003 Endotoxin and Kupffer cell activation in alcoholic liver disease. Alcohol Res Health 27:300-306
146. Adachi Y, Bradford BU, Gao W, Bojes HK, Thurman RG 1994 Inactivation of Kupffer cells prevents early alcoholinduced liver injury. Hepatology 20:453-460 (Pubitemid 24233374)
147. Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Grose RH, Cummins AG 2001 The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor α in the pathogenesis of non-alcoholic steatohepatitis. Gut 48:206-211
148. Drenick EJ, Fisler J, Johnson D 1982 Hepatic steatosis after intestinal bypass - prevention and reversal by metronidazole, irrespective of protein-calorie malnutrition. Gastroenterology 82:535-548 (Pubitemid 12166814)
149. Miele L, Valenza V, La Torre G, Montalto M, Cammarota G, Ricci R, Mascianà R, Forgione A, Gabrieli ML, Perotti G, Vecchio FM, Rapaccini G, Gasbarrini G, Day CP, Grieco A 2009 Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 49:1877-1887
150. Lichtman SN, Keku J, Schwab JH, Sartor RB 1991 Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline. Gastroenterology 100:513-519
151. Loguercio C, De Simone T, Federico A, Terracciano F, Tuccillo C, Di Chicco M, Cartenì M 2002 Gut-liver axis: a new point of attack to treat chronic liver damage? Am J Gastroenterol 97:2144-2146
152. Li Z, Yang S, Lin H, Huang J, Watkins PA, Moser AB, Desimone C, Song XY, Diehl AM 2003 Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 37:343-350 (Pubitemid 36152533)
153. Huang J, Sloop CH, Roheim PS, Wong L 1990 Lipoprotein lipase and hepatic triacylglycerol lipase activities in peripheral and skeletal muscle lymph. Arteriosclerosis 10:720-726 (Pubitemid 20273344)
154. Mead JR, Irvine SA, Ramji DP 2002 Lipoprotein lipase: structure, function, regulation, and role in disease. J Mol Med 80:753-769
155. Liao W 1996 Endotoxin: possible roles in initiation and development of atherosclerosis. J Lab Clin Med 128:452-460 (Pubitemid 27506770)
156. Arroyo-Espliguero R, Avanzas P, Jeffery S, Kaski JC 2004 CD14 and toll-like receptor 4: a link between infection and acute coronary events? Heart 90:983-988
157. Partridge J, Carlsen H, Enesa K, Chaudhury H, Zakkar M, Luong L,
158. Boullier A, Friedman P, Harkewicz R, Hartvigsen K, Green SR, Almazan F, Dennis EA, Steinberg D, Witztum JL, Quehenberger O 2005 Phosphocholine as a pattern recognition ligand for CD36. J Lipid Res 46:969-976
159. Miller YI, Viriyakosol S, Binder CJ, Feramisco JR, Kirkland TN, Witztum JL 2003 Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J Biol Chem 278:1561-1568 (Pubitemid 36801384)
160. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS 2006 TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116:3015-3025 (Pubitemid 44684486)
161. Suganami T, Tanimoto-Koyama K, Nishida J, Itoh M, Yuan X, Mizuarai S, Kotani H, Yamaoka S, Miyake K, Aoe S, Kamei Y, Ogawa Y 2007 Role of the Toll-like receptor 4/NF-κB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 27:84-91
162. Lin L, Park S, Lakatta EG 2009 RAGE signaling in inflammation and arterial aging. Front Biosci 14:1403-1413
163. Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K, Freudenberg M, Galanos C, Simon JC 2002 Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 195:99-111 (Pubitemid 34074500)
164. Curtiss LK, Tobias PS 2009 Emerging role of Toll-like receptors in atherosclerosis. J Lipid Res 50 Suppl:S340-S345
165. Mullick AE, Soldau K, Kiosses WB, Bell 3rd TA, Tobias PS, Curtiss LK 2008 Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events. J Exp Med 205:373-383 (Pubitemid 351281603)
166. Gibbs LS, Del Vecchio PJ, Shaffer JB 1992 Mn and Cu/Zn SOD expression in cells from LPS-sensitive and LPS-resistant mice. Free Radic Biol Med 12:107-111
167. Sweet MJ, Hume DA 1996 Endotoxin signal transduction in macrophages. J Leukoc Biol 60:8-26
168. Stoll LL, Denning GM, Li WG, Rice JB, Harrelson AL, Romig SA, Gunnlaugsson ST, Miller Jr FJ, Weintraub NL 2004 Regulation of endotoxin-induced proinflammatory activation in human coronary artery cells: expression of functional membrane-bound CD14 by human coronary artery smooth muscle cells. J Immunol 173:1336-1343
169. Rice JB, Stoll LL, Li WG, Denning GM, Weydert J, Charipar E, Richenbacher WE, Miller Jr FJ, Weintraub NL 2003 Low-level endotoxin induces potent inflammatory activation of human blood vessels: inhibition by statins. Arterioscler Thromb Vasc Biol 23:1576-1582 (Pubitemid 37108200)
170. Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Ding HA, Gimbrone Jr MA, Luster AD, Luscinskas FW, Rosenzweig A 1999 MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398:718-723 (Pubitemid 29197651)
171. Larsen CG, Anderson AO, Appella E, Oppenheim JJ, Matsushima K 1989 The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 243:1464-1466 (Pubitemid 19087128)
172. Shen Y, Sultana C, Arditi M, Kim KS, Kalra VK 1998 Endotoxin-induced migration of monocytes and PECAM-1 phosphorylation are abrogated by PAF receptor antagonists. Am J Physiol 275:E479-E486
173. Pahan K, Sheikh FG, Namboodiri AM, Singh I 1997 Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J Clin Invest 100:2671-2679 (Pubitemid 28007534)
174. Bannerman DD, Goldblum SE 2003 Mechanisms of bacterial lipopolysaccharide-induced endothelial apoptosis. Am J Physiol Lung Cell Mol Physiol 284:L899-L914 (Pubitemid 36687124)
175. Frey EA, Finlay BB 1998 Lipopolysaccharide induces apoptosis in a bovine endothelial cell line via a soluble CD14 dependent pathway. Microb Pathog 24:101-109
176. Liston P, Roy N, Tamai K, Lefebvre C, Baird S, Cherton-Horvat G, Farahani R, McLean M, Ikeda JE, MacKenzie A, Korneluk RG 1996 Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 379:349-353 (Pubitemid 26033078)
177. Hida A, Kawakami A, Nakashima T, Yamasaki S, Sakai H, Urayama S, Ida H, Nakamura H, Migita K, Kawabe Y, Eguchi K 2000 Nuclear factor-κB and caspases co-operatively regulate the activation and apoptosis of human macrophages. Immunology 99:553-560 (Pubitemid 30201002)
178. Heidenreich S 1999 Monocyte CD14: a multifunctional receptor engaged in apoptosis from both sides. J Leukoc Biol 65:737-743 (Pubitemid 29279520)
179. Wiedermann CJ, Kiechl S, Dunzendorfer S, Schratzberger P, Egger G, Oberhollenzer F, Willeit J 1999 Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck study. J Am Coll Cardiol 34:1975-1981 (Pubitemid 30002653)
180. Miller MA, McTernan PG, Harte AL, Silva NF, Strazzullo P, Alberti KG, Kumar S, Cappuccio FP 2009 Ethnic and sex differences in circulating endotoxin levels: a novel marker of atherosclerotic and cardiovascular risk in a British multi-ethnic population. Atherosclerosis 203:494-502
181. Cappuccio FP, Oakeshott P, Strazzullo P, Kerry SM 2002 Application of Framingham risk estimates to ethnic minorities in United Kingdom and implications for primary prevention of heart disease in general practice: cross-sectional population based study. BMJ 325:1271
182. Fogelstrand L, Hulthe J, Hultén LM, Wiklund O, Fagerberg B 2004 Monocytic expression of CD14 and CD18, circulating adhesion molecules and inflammatory markers in women with diabetes mellitus and impaired glucose tolerance. Diabetologia 47:1948-1952 (Pubitemid 40110203)
183. Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I 1997 Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 46:860-867 (Pubitemid 27188265)
184. Thomas EL, Saeed N, Hajnal JV, Brynes A, Goldstone AP, Frost G, Bell JD 1998 Magnetic resonance imaging of total body fat. J Appl Physiol 85:1778-1785 (Pubitemid 28516412)
185. Fabbrini E, Magkos F, Mohammed BS, Pietka T, Abumrad NA, Patterson BW, Okunade A, Klein S 2009 Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci USA 106:15430-15435
186. Gastaldelli A, Miyazaki Y, Pettiti M, Matsuda M, Mahankali S, Santini E, DeFronzo RA, Ferrannini E 2002 Metabolic effects of visceral fat accumulation in type 2 diabetes. J Clin Endocrinol Metab 87:5098-5103 (Pubitemid 35316351)
187. Goldberg IJ, Eckel RH, Abumrad NA 2009 Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CD36-mediated pathways. J Lipid Res 50 Suppl:S86-S90
188. Cousin B, Munoz O, Andre M, Fontanilles AM, Dani C, Cousin JL, Laharrague P, Casteilla L, Pénicaud L 1999 A role for preadipocytes as macrophage-like cells. FASEB J 13:305-312
189. Charrière G, Cousin B, Arnaud E, André M, Bacou F, Penicaud L, Casteilla L 2003 Preadipocyte conversion to macrophage. Evidence of plasticity. J Biol Chem 278:9850-9855 (Pubitemid 36800488)
190. Hotamisligil GS, Shargill NS, Spiegelman BM 1993 Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259:87-91
191. Bouloumié A, Sengenès C, Portolan G, Galitzky J, Lafontan M 2001 Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation. Diabetes 50: 2080-2086 (Pubitemid 33643675)
192. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM 1998 PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93:241-252 (Pubitemid 28180857)
193. Fried SK, Bunkin DA, Greenberg AS 1998 Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83:847-850
194. Hauner H 2005 Secretory factors from human adipose tissue and their functional role. Proc Nutr Soc 64:163-169 (Pubitemid 40813538)
195. Lin Y, Lee H, Berg AH, Lisanti MP, Shapiro L, Scherer PE 2000 The lipopolysaccharide-activated toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes. J Biol Chem 275:24255-24263 (Pubitemid 30626513)
196. Berg AH, Lin Y, Lisanti MP, Scherer PE 2004 Adipocyte differentiation induces dynamic changes in NF-κB expression and activity. Am J Physiol Endocrinol Metab 287:E1178-E1188 (Pubitemid 39491960)
197. Skurk T, Herder C, Kräft I, Müller-Scholze S, Hauner H, Kolb H 2005 Production and release of macrophage migration inhibitory factor from human adipocytes. Endocrinology 146:1006-1011 (Pubitemid 40289288)
198. Lee JY, Zhao L, Youn HS, Weatherill AR, Tapping R, Feng L, Lee WH, Fitzgerald KA, Hwang DH 2004 Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J Biol Chem 279:16971-16979 (Pubitemid 38560450)
199. Wong SW, Kwon MJ, Choi AM, Kim HP, Nakahira K, Hwang DH 2009 Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J Biol Chem 284:27384-27392
200. Venet C, Zeni F, Viallon A, Ross A, Pain P, Gery P, Page D, Vermesch R, Bertrand M, Rancon F, Bertrand JC 2000 Endotoxaemia in patients with severe sepsis or septic shock. Intensive Care Med 26:538-544 (Pubitemid 30325869)
201. Senn JJ 2006 Toll-like receptor-2 is essential for the development of palmitate-induced insulin resistance in myotubes. J Biol Chem 281:26865-26875
202. Kim F, Pham M, Luttrell I, Bannerman DD, Tupper J, Thaler J, Hawn TR, Raines EW, Schwartz MW 2007 Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ Res 100:1589-1596 (Pubitemid 46897262)
203. Erridge C, Samani NJ 2009 Saturated fatty acids do not directly stimulate Toll-like receptor signaling. Arterioscler Thromb Vasc Biol 29:1944-1949
204. Manco M, Calvani M, Mingrone G 2004 Effects of dietary fatty acids on insulin sensitivity and secretion. Diabetes Obes Metab 6:402-413 (Pubitemid 39409791)
205. Miller YI, Viriyakosol S, Worrall DS, Boullier A, Butler S, Witztum JL 2005 Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler Thromb Vasc Biol 25:1213-1219 (Pubitemid 40776611)
206. Dasu MR, Devaraj S, Zhao L, Hwang DH, Jialal I 2008 High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes 57: 3090-3098
207. Johnson GB, Riggs BL, Platt JL 2004 A genetic basis for the "Adonis" phenotype of low adiposity and strong bones. FASEB J 18:1282-1284
208. Poggi M, Bastelica D, Gual P, Iglesias MA, Gremeaux T, Knauf C, Peiretti F, Verdier M, Juhan-Vague I, Tanti JF, Burcelin R, Alessi MC 2007 C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet. Diabetologia 50:1267-1276
209. Tsukumo DM, Carvalho-Filho MA, Carvalheira JB, Prada PO, Hirabara SM, Schenka AA, Araújo EP, Vassallo J, Curi R, Velloso LA, Saad MJ 2007 Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 56:1986-1998 (Pubitemid 47195825)
210. Amar J, Burcelin R, Ruidavets JB, Cani PD, Fauvel J, Alessi MC, Chamontin B, Ferriéres J 2008 Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr 87:1219-1223 (Pubitemid 351679761)
211. Fernández-Real JM, Broch M, Richart C, Vendrell J, López-Bermejo A, Ricart W 2003 CD14 monocyte receptor, involved in the inflammatory cascade, and insulin sensitivity. J Clin Endocrinol Metab 88:1780-1784 (Pubitemid 36623404)
212. Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, Martinez FD 1999 A Polymorphism* in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 20:976-983 (Pubitemid 129540855)
213. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, Frees K, Watt JL, Schwartz DA 2000 TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25:187-191 (Pubitemid 30394990)
214. Kolek MJ, Carlquist JF, Muhlestein JB, Whiting BM, Horne BD, Bair TL, Anderson JL 2004 Toll-like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetes. Am Heart J 148:1034-1040
215. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, Willeit J, Schwartz DA 2002 Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347:185-192
216. Peter K, Nawroth P, Conradt C, Nordt T, Weiss T, Boehme M, Wunsch A, Allenberg J, Kübler W, Bode C 1997 Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler Thromb Vasc Biol 17:505-512 (Pubitemid 27133140)
217. Ameziane N, Beillat T, Verpillat P, Chollet-Martin S, Aumont MC, Seknadji P, Lamotte M, Lebret D, Ollivier V, de Prost D 2003 Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events. Arterioscler Thromb Vasc Biol 23:e61-e64
218. Yang IA, Holloway JW, Ye S, Southampton Atherosclerosis Study (SAS) Group 2003 TLR4 Asp299Gly polymorphism is not associated with coronary artery stenosis. Atherosclerosis 170:187-190 (Pubitemid 37086707)
219. Boekholdt SM, Agema WR, Peters RJ, Zwinderman AH, van der Wall EE, Reitsma PH, Kastelein JJ, Jukema JW, REgression GRowth Evaluation Statin Study Group 2003 Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events. Circulation 107:2416-2421
220. Membrez M, Blancher F, Jaquet M, Bibiloni R, Cani PD, Burcelin RG, Corthesy I, Macé K, Chou CJ 2008 Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J 22:2416-2426 (Pubitemid 351948659)
221. Bergheim I, Weber S, Vos M, Krämer S, Volynets V, Kaserouni S, McClain CJ, Bischoff SC 2008 Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J Hepatol 48:983-992
222. Watzl B, Girrbach S, Roller M 2005 Inulin, oligofructose and immunomodulation. Br J Nutr 93(Suppl 1):S49-S55
223. Roberfroid M 2007 Prebiotics: the concept revisited. J Nutr 137:830S-837S
224. Thuy S, Ladurner R, Volynets V, Wagner S, Strahl S, Königsrainer A, Maier KP, Bischoff SC, Bergheim I 2008 Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr 138:1452-1455
225. Nanji AA, Khettry U, Sadrzadeh SM 1994 Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease). Proc Soc Exp Biol Med 205:243-247 (Pubitemid 24108319)
226. Delzenne N, Reid G 2009 No causal link between obesity and probiotics. Nat Rev Microbiol 7:901; author reply 901
227. Loguercio C, Federico A, Tuccillo C, Terracciano F, D'Auria MV, De Simone C, Del Vecchio Blanco C 2005 Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases. J Clin Gastroenterol 39:540-543 (Pubitemid 40863651)
228. Ghanim H, Abuaysheh S, Sia CL, Korzeniewski K, Chaudhuri A, Fernandez-Real JM, Dandona P 2009 Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care 32:2281-2287
229. Velayudham A, Dolganiuc A, Ellis M, Petrasek J, Kodys K, Mandrekar P, Szabo G 2009 VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice. Hepatology 49:989-997
230. Ewaschuk J, Endersby R, Thiel D, Diaz H, Backer J, Ma M, Churchill T, Madsen K 2007 Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis. Hepatology 46:841-850 (Pubitemid 47436131)
231. Park BS, Song DH, Kim HM, Choi BS, Lee H, Lee JO 2009 The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458:1191-1195
232. Rossignol DP, Lynn M 2002 Antagonism of in vivo and ex vivo response to endotoxin by E5564, a synthetic lipid A analogue. J Endotoxin Res 8:483-488 (Pubitemid 36104606)
233. Mullarkey M, Rose JR, Bristol J, Kawata T, Kimura A, Kobayashi S, Przetak M, Chow J, Gusovsky F, Christ WJ, Rossignol DP 2003 Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist. J Pharmacol Exp Ther 304:1093-1102 (Pubitemid 36254422)
234. Fort MM, Mozaffarian A, Stöver AG, Correia Jda S, Johnson DA, Crane RT, Ulevitch RJ, Persing DH, Bielefeldt-Ohmann H, Probst P, Jeffery E, Fling SP, Hershberg RM 2005 A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease. J Immunol 174:6416-6423
235. Kawamoto T, Ii M, Kitazaki T, Iizawa Y, Kimura H 2008 TAK-242selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain. Eur J Pharmacol 584:40-48
236. Sha T, Sunamoto M, Kitazaki T, Sato J, Ii M, Iizawa Y 2007 Therapeutic effects of TAK-242, a novel selective Toll-like receptor 4 signal transduction inhibitor, in mouse endotoxin shock model. Eur J Pharmacol 571:231-239 (Pubitemid 47379694)
237. Kanzler H, Barrat FJ, Hessel EM, Coffman RL 2007 Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat Med 13:552-559 (Pubitemid 46830615)
238. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI 2007 Thehumanmicrobiome project. Nature 449:804-810
239. Akira S, Uematsu S, Takeuchi O 2006 Pathogen recognition and innate immunity. Cell 124:783-801
240. Medzhitov R 2001 Toll-like receptors and innate immunity. Nat Rev Immunol 1:135-145
241. Lu YC, Yeh WC, Ohashi PS 2008 LPS/TLR4 signal transduction pathway. Cytokine 42:145-151
242. O'Neill LA, Bowie AG 2007 The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 7:353-364
243. Woese CR, Kandler O, Wheelis ML 1990 Towards a natural system of organisms: proposal for the domains Archaea, Bacteria, and Eucarya. Proc Natl Acad Sci USA 87:4576-4579
244. Turnbaugh PJ, Bäckhed F, Fulton L, Gordon JI 2008 Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3:213-223 (Pubitemid 351494716)
245. Danner RL, Elin RJ, Hosseini JM, Wesley RA, Reilly JM, Parillo JE 1991 Endotoxemia in human septic shock. Chest 99:169-175
246. Goto T, Edén S, Nordenstam G, Sundh V, Svanborg-Edén C, Mattsby-Baltzer I 1994 Endotoxin levels in sera of elderly individuals. Clin Diagn Lab Immunol 1:684-688 (Pubitemid 2164296)
247. Lin RS, Lee FY, Lee SD, Tsai YT, Lin HC, Lu RH, Hsu WC, Huang CC, Wang SS, Lo KJ 1995 Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. J Hepatol 22:165-172
248. Niebauer J, Volk HD, Kemp M, Dominguez M, Schumann RR, Rauchhaus M, Poole-Wilson PA, Coats AJ, Anker SD 1999 Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 353:1838-1842 (Pubitemid 29251016)
249. Cohen J 2000 The detection and interpretation of endotoxaemia. Intensive Care Med 26 Suppl 1:S51-S56